14 results on '"Straub, Adam C."'
Search Results
2. Hemin and iron increase synthesis and trigger export of xanthine oxidoreductase from hepatocytes to the circulation
- Author
-
DeVallance, Evan R., Schmidt, Heidi M., Seman, Madison, Lewis, Sara E., Wood, Katherine C., Vickers, Schuyler D., Hahn, Scott A., Velayutham, Murugesan, Hileman, Emily A., Vitturi, Dario A., Leonardi, Roberta, Straub, Adam C., and Kelley, Eric E.
- Published
- 2023
- Full Text
- View/download PDF
3. Release of hepatic xanthine oxidase (XO) to the circulation is protective in intravascular hemolytic crisis
- Author
-
Schmidt, Heidi M., DeVallance, Evan R., Lewis, Sara E., Wood, Katherine C., Annarapu, Gowtham K., Carreño, Mara, Hahn, Scott A., Seman, Madison, Maxwell, Brooke A., Hileman, Emily A., Xu, Julia Z., Velayutham, Murugesan, Geldenhuys, Werner J., Vitturi, Dario A., Shiva, Sruti, Kelley, Eric E., and Straub, Adam C.
- Published
- 2023
- Full Text
- View/download PDF
4. Cooperation between CYB5R3 and NOX4 via coenzyme Q mitigates endothelial inflammation
- Author
-
Yuan, Shuai, Hahn, Scott A., Miller, Megan P., Sanker, Subramaniam, Calderon, Michael J., Sullivan, Mara, Dosunmu-Ogunbi, Atinuke M., Fazzari, Marco, Li, Yao, Reynolds, Michael, Wood, Katherine C., St Croix, Claudette M., Stolz, Donna, Cifuentes-Pagano, Eugenia, Navas, Placido, Shiva, Sruti, Schopfer, Francisco J., Pagano, Patrick J., and Straub, Adam C.
- Published
- 2021
- Full Text
- View/download PDF
5. Redox control of vascular smooth muscle cell function and plasticity.
- Author
-
Durgin, Brittany G. and Straub, Adam C.
- Published
- 2018
- Full Text
- View/download PDF
6. Cytochrome b5 reductases: Redox regulators of cell homeostasis.
- Author
-
Hall, Robert, Shuai Yuan, Wood, Katherine, Katona, Mate, and Straub, Adam C.
- Subjects
- *
REDUCTASES , *OXIDATION-reduction reaction , *GENETIC variation , *HOMEOSTASIS , *CONGENITAL disorders , *FLAVOPROTEINS - Abstract
The cytochrome-b5 reductase (CYB5R) family of flavoproteins is known to regulate reduction-oxidation (redox) balance in cells. The five enzyme members are highly compartmentalized at the subcellular level and function as "redox switches" enabling the reduction of several substrates, such as heme and coenzyme Q. Critical insight into the physiological and path-ophysiological significance of CYB5R enzymes has been gleaned from several human genetic variants that cause congenital disease and a broad spectrum of chronic human diseases. Among the CYB5R genetic variants, CYB5R3 is well-characterized and deficiency in expression and activity is associated with type II methemoglobinemia, cancer, neurode-generative disorders, diabetes, and cardiovascular disease. Importantly, pharmacological and genetic-based strategies are underway to target CYB5R3 to circumvent disease onset and mitigate severity. Despite our knowledge of CYB5R3 in human health and disease, the other reductases in the CYB5R family have been understudied, providing an opportunity to unravel critical function(s) for these enzymes in physiology and disease. In this review, we aim to provide the broad scientific community an up-to-date overview of the molecular, cellular, physiological, and pathophysiological roles of CYB5R proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. The airway smooth muscle sodium/calcium exchanger NCLX is critical for airway remodeling and hyperresponsiveness in asthma.
- Author
-
Johnson, Martin T., Benson, J. Cory, Pathak, Trayambak, Ping Xin, McKernan, Abagail S., Emrich, Scott M., Yoast, Ryan E., Walter, Vonn, Straub, Adam C., and Trebak, Mohamed
- Subjects
- *
SMOOTH muscle , *ASTHMA , *CELL imaging , *CELL migration , *RESPIRATORY measurements , *CALCIUM metabolism , *CALMODULIN , *CALCIUM channels - Abstract
The structural changes of airway smooth muscle (ASM) that characterize airway remodeling (AR) are crucial to the pathogenesis of asthma. During AR, ASM cells dedifferentiate from a quiescent to a proliferative, migratory, and secretory phenotype. Calcium (Ca2+) is a ubiquitous second messenger that regulates many cellular processes, including proliferation, migration, contraction, and metabolism. Furthermore, mitochondria have emerged as major Ca2+ signaling organelles that buffer Ca2+ through uptake by the mitochondrial Ca2+ uniporter and extrude it through the Na+/Ca2+ exchanger (NCLX/Slc8b1). Here, we show using mitochondrial Ca2+-sensitive dyes that NCLX only partially contributes to mitochondrial Ca2+ extrusion in ASM cells. Yet, NCLX is necessary for ASM cell proliferation and migration. Through cellular imaging, RNA-Seq, and biochemical assays, we demonstrate that NCLX regulates these processes by preventing mitochondrial Ca2+ overload and supporting store-operated Ca2+ entry, activation of Ca2+/calmodulin-dependent kinase II, and transcriptional and metabolic reprogramming. Using small animal respiratory mechanic measurements and immunohistochemistry, we show that smooth muscle-specific NCLX KO mice are protected against AR, fibrosis, and hyperresponsiveness in an experimental model of asthma. Our findings support NCLX as a potential therapeutic target in the treatment of asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Human and rodent red blood cells do not demonstrate xanthine oxidase activity or XO-catalyzed nitrite reduction to NO.
- Author
-
Lewis, Sara E., Rosencrance, Courtney B., De Vallance, Evan, Giromini, Andrew, Williams, Xena M., Oh, Joo-Yeun, Schmidt, Heidi, Straub, Adam C., Chantler, Paul D., Patel, Rakesh P., and Kelley, Eric E.
- Subjects
- *
ERYTHROCYTES , *XANTHINE oxidase , *NITRITE reductase , *NITRATE reductase , *RODENTS , *NITRITES - Abstract
A number of molybdopterin enzymes, including xanthine oxidoreductase (XOR), aldehyde oxidase (AO), sulfite oxidase (SO), and mitochondrial amidoxime reducing component (mARC), have been identified as nitrate and nitrite reductases. Of these enzymes, XOR has been the most extensively studied and reported to be a substantive source of nitric oxide (NO) under inflammatory/hypoxic conditions that limit the catalytic activity of the canonical NOS pathway. It has also been postulated that XOR nitrite reductase activity extends to red blood cell (RBCs) membranes where it has been immunohistochemically identified. These findings, when combined with countervailing reports of XOR activity in RBCs, incentivized our current study to critically evaluate XOR protein abundance/enzymatic activity in/on RBCs from human, mouse, and rat sources. Using various protein concentrations of RBC homogenates for both human and rodent samples, neither XOR protein nor enzymatic activity (xanthine → uric acid) was detectable. In addition, potential loading of RBC-associated glycosaminoglycans (GAGs) by exposing RBC preparations to purified XO before washing did not solicit detectable enzymatic activity (xanthine → uric acid) or alter NO generation profiles. To ensure these observations extended to absence of XOR-mediated contributions to overall RBC-associated nitrite reduction, we examined the nitrite reductase activity of washed and lysed RBC preparations via enhanced chemiluminescence in the presence or absence of the XOR-specific inhibitor febuxostat (Uloric®). Neither addition of inhibitor nor the presence of the XOR substrate xanthine significantly altered the rates of nitrite reduction to NO by RBC preparations from either human or rodent sources confirming the absence of XO enzymatic activity. Furthermore, examination of the influence of the age (young cells vs. old cells) of human RBCs on XO activity also failed to demonstrate detectable XO protein. Combined, these data suggest: 1) that XO does not contribute to nitrite reduction in/on human and rodent erythrocytes, 2) care should be taken to validate immuno-detectable XO by demonstrating enzymatic activity, and 3) XO does not associate with human erythrocytic glycosaminoglycans or participate in nonspecific binding. [Display omitted] • Reported immunocytochemical evidence suggest the presence of XO in/on RBCs. • Assessment of rodent and human RBCs herein reveals neither XO protein nor XO/XDH activity. • Human and rodent RBCs do not demonstrate XO-dependent nitrite reductase activity. • Conclusions based on nonspecific antibodies require validation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. CoenzymeQ in cellular redox regulation and clinical heart failure.
- Author
-
Yuan, Shuai, Schmidt, Heidi M., Wood, Katherine C., and Straub, Adam C.
- Subjects
- *
UBIQUINONES , *HEART failure , *NEPRILYSIN , *OXIDATION-reduction reaction , *HEART failure patients , *BILAYER lipid membranes , *MULTIENZYME complexes - Abstract
Coenzyme Q (CoQ) is ubiquitously embedded in lipid bilayers of various cellular organelles. As a redox cycler, CoQ shuttles electrons between mitochondrial complexes and extramitochondrial reductases and oxidases. In this way, CoQ is crucial for maintaining the mitochondrial function, ATP synthesis, and redox homeostasis. Cardiomyocytes have a high metabolic rate and rely heavily on mitochondria to provide energy. CoQ levels, in both plasma and the heart, correlate with heart failure in patients, indicating that CoQ is critical for cardiac function. Moreover, CoQ supplementation in clinics showed promising results for treating heart failure. This review provides a comprehensive view of CoQ metabolism and its interaction with redox enzymes and reactive species. We summarize the clinical trials and applications of CoQ in heart failure and discuss the caveats and future directions to improve CoQ therapeutics. [Display omitted] • CoQ is an indispensable component in the mitochondrial respiratory chain. • The redox status of CoQ is regulated by mitochondrial complexes and other enzymes in different subcellular compartments. • CoQ, in both reduced and oxidized forms, interacts with a myriad of reactive species. • CoQ has been implemented in treating cardiovascular disease for decades and showed potentials as a therapy for heart failure. • More rigorous clinical trials are needed to appreciate CoQ's clinical value as a therapeutic approach against heart failure. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite Synergistically Enhances Nitric Oxide Production and Microvascular Perfusion.
- Author
-
Yu, Gary Z., Istvanic, Filip, Chen, Xucai, Nouraie, Mehdi, Shiva, Sruti, Straub, Adam C., and Pacella, John J.
- Subjects
- *
SODIUM nitrites , *NITRIC oxide , *PERFUSION , *CAVITATION , *NITRIC-oxide synthases , *SOUND pressure , *INTRA-aortic balloon counterpulsation - Abstract
Microvascular obstruction is a common repercussion of percutaneous coronary intervention for distal microembolization, ischemia-reperfusion injury and inflammation, which increases post-myocardial infarction heart failure and mortality. Ultrasound-targeted microbubble cavitation (UTMC) may resolve microvascular obstruction while activating endothelial nitric oxide synthase (eNOS) and increasing endothelium-derived nitric oxide (NO) bioavailability. Nitrite, a cardioprotective agent, offers an additional source of NO and potential synergy with UTMC. UTMC and nitrite co-therapy increased microvascular perfusion and NO concentration in a rat hindlimb model. Using N-nitro-L-arginine methyl ester for eNOS blockade, we found a three-way interaction effect between nitrite, UTMC and eNOS on microvascular perfusion and NO production. Modulating ultrasound peak negative acoustic pressure (0.33-1.5 MPa) significantly affected outcomes, while microbubble dosage (2 × 108 bubbles/mL, 1.5 mL/h to 1 × 109 bubbles/mL, 3 mL/h) did not. Nitrite co-therapy also protected against oxidative stress. Comparison of nitrite to sodium nitroprusside with UTMC revealed synergistic effects were specific to nitrite. Synergy between UTMC and nitrite holds therapeutic potential for cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. Two functionally distinct pools of eNOS in endothelium are facilitated by myoendothelial junction lipid composition.
- Author
-
Biwer, Lauren A., Taddeo, Evan P., Kenwood, Brandon M., Hoehn, Kyle L., Straub, Adam C., and Isakson, Brant E.
- Subjects
- *
NITRIC-oxide synthases , *ENDOTHELIAL cells , *SMOOTH muscle , *PHENYLEPHRINE , *SYMPATHOMIMETIC agents , *PHOSPHATIDYLSERINES , *BRADYKININ , *THERAPEUTICS - Abstract
In resistance arteries, endothelial cells (EC) make contact with smooth muscle cells (SMC), forming myoendothelial junctions (MEJ). Endothelial nitric oxide synthase (eNOS) is present in the luminal side of the EC (apical EC) and the basal side of the EC (MEJ). To test if these eNOS pools acted in sync or separately, we co-cultured ECs and SMCs, then stimulated SMCs with phenylephrine (PE). Adrenergic activation causes inositol [1,4,5] triphosphate (IP 3 ) to move from SMC to EC through gap junctions at the MEJ. PE increases MEJ eNOS phosphorylation (eNOS-P) at S1177, but not in EC. Conversely, we used bradykinin (BK) to increase EC calcium; this increased EC eNOS-P but did not affect MEJ eNOS-P. Inhibiting gap junctions abrogated the MEJ eNOS-P after PE, but had no effect on BK eNOS-P. Differential lipid composition between apical EC and MEJ may account for the compartmentalized eNOS-P response. Indeed, DAG and phosphatidylserine are both enriched in MEJ. These lipids are cofactors for PKC activity, which was significantly increased at the MEJ after PE. Because PKC activity also relies on endoplasmic reticulum (ER) calcium release, we used thapsigargin and xestospongin C, BAPTA, and PKC inhibitors, which caused significant decreases in MEJ eNOS-P after PE. Functionally, BK inhibited leukocyte adhesion and PE caused an increase in SMC cGMP. We hypothesize that local lipid composition of the MEJ primes PKC and eNOS-P for stimulation by PE, allowing for compartmentalized function of eNOS in the blood vessel wall. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Structure Guided Chemical Modifications of Propylthiouracil Reveal Novel Small Molecule Inhibitors of Cytochrome b5 Reductase 3 That Increase Nitric Oxide Bioavailability.
- Author
-
Rahaman, Md. Mizanur, Reinders, Fabio G., Koes, David, Nguyen, Anh T., Mutchler, Stephanie M., Sparacino-Watkins, Courtney, Alvarez, Roger A., Miller, Megan P., Dongmei Cheng, Chen, Bill B., Jackson, Edwin K., Camacho, Carlos J., and Straub, Adam C.
- Subjects
- *
CYTOCHROME b5 reductase , *SMALL molecules , *NITRIC oxide , *BIOAVAILABILITY , *CHOLESTEROL , *DRUG metabolism , *METHEMOGLOBIN , *DRUG development - Abstract
NADH cytochrome b5 reductase 3 (CYB5R3) is critical for reductive reactions such as fatty acid elongation, cholesterol biosynthesis, drug metabolism and methemoglobin reduction. While the physiological and metabolic importance of CYB5R3 has been established in hepatocytes and erythrocytes, emerging investigations suggest that CYB5R3 is critical for nitric oxide signaling and vascular function. However, advancement toward fully understanding CYB5R3 function has been limited due to a lack of potent small molecule inhibitors. Because of this restriction, we modeled the binding mode of propylthiouracil (PTU), a weak inhibitor of CYB5R3 (IC50= ~275 µM), and used it as a guide to predict thiouracil-biased inhibitors from the set of commercially available compounds in the ZINC database. Using this approach, we validated two new potent derivatives of PTU, ZINC05626394 (IC50 = 10.81 µM) and ZINC39395747 (IC50 = 9.14 µM), both of which inhibit CYB5R3 activity in cultured cells. Moreover, we found that ZINC39395747 significantly increased NO bioavailability in renal vascular cells, augmented renal blood flow and decreased systemic blood pressure in response to vasoconstrictors in spontaneously hypertensive rats. These compounds will serve as a new tool to examine the biological functions of CYB5R3 in physiology and disease and also as a platform for new drug development. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. H3K4 di-methylation governs smooth muscle lineage identity and promotes vascular homeostasis by restraining plasticity.
- Author
-
Liu, Mingjun, Espinosa-Diez, Cristina, Mahan, Sidney, Du, Mingyuan, Nguyen, Anh T., Hahn, Scott, Chakraborty, Raja, Straub, Adam C., Martin, Kathleen A., Owens, Gary K., and Gomez, Delphine
- Subjects
- *
SMOOTH muscle , *DNA demethylation , *VASCULAR smooth muscle , *HISTONES , *VASCULAR remodeling , *CARDIOVASCULAR diseases , *HOMEOSTASIS - Abstract
Epigenetic mechanisms contribute to the regulation of cell differentiation and function. Vascular smooth muscle cells (SMCs) are specialized contractile cells that retain phenotypic plasticity even after differentiation. Here, by performing selective demethylation of histone H3 lysine 4 di-methylation (H3K4me2) at SMC-specific genes, we uncovered that H3K4me2 governs SMC lineage identity. Removal of H3K4me2 via selective editing in cultured vascular SMCs and in murine arterial vasculature led to loss of differentiation and reduced contractility due to impaired recruitment of the DNA methylcytosine dioxygenase TET2. H3K4me2 editing altered SMC adaptative capacities during vascular remodeling due to loss of miR-145 expression. Finally, H3K4me2 editing induced a profound alteration of SMC lineage identity by redistributing H3K4me2 toward genes associated with stemness and developmental programs, thus exacerbating plasticity. Our studies identify the H3K4me2-TET2-miR145 axis as a central epigenetic memory mechanism controlling cell identity and function, whose alteration could contribute to various pathophysiological processes. [Display omitted] • Gene-selective epigenome editing reveals that H3K4me2 controls SMC lineage identity • H3K4me2 editing induces loss of contractility and exacerbates phenotypic plasticity • H3K4me2 interacts with TET2 and mediates TET-dependent gene activation • Loss of H3K4me2 impairs SMC-mediated vascular remodeling due to miR-145 deficiency Regulating the contractile states of smooth muscle cells (SMCs) is critical for vascular homeostasis. Liu et al. find that the H3K4me2 modification is required to maintain SMC lineage identity and contractile state, serving as a genomic footprint for TET2-mediated DNA demethylation. H3K4me2 alteration in SMCs may contribute to cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. P-294 - Detection of brain cardiolipins in plasma after cardiac arrest.
- Author
-
Bayır, Hülya, Anthonymuthu, Tamil S., Kenny, Elizabeth M., Lamade, Andrew M., Gidwani, Hitesh, Krehel, Nicholas M., Misse, Amalea, Amoscato, Andrew A., Straub, Adam C., Dezfulian, Cameron, and Kagan, Valerian E.
- Subjects
- *
CARDIOLIPIN , *PHOSPHOLIPIDS , *BRAIN , *RADIOGRAPHY , *BRAIN function localization , *CARDIAC arrest , *PLASMA cell diseases , *GENETICS , *GENE therapy - Abstract
Neurological injury resulting from dysfunction of brain mitochondria limits recovery after cardiac arrest (CA). Available indicators of neurological injury are inadequate for early prognostication after return of spontaneous circulation (ROSC). High diversification and essentiality of brain mitochondrial cardiolipins (CL) makes them unique candidates to quantify brain injury and predict prognosis early after ROSC. Using high-resolution liquid chromatography mass spectrometry, we determined CL content in plasma from 39 patients within 6 h of ROSC, 10 healthy controls and human heart and brain tissue. Cerebral score (C-score) was derived from brain-specific CL. Using a rat model of CA, CL was quantified in plasma and brain and results were compared with the controls. Brain and heart fell on extreme ends of CL diversity spectrum. Nine of 26 brain-specific CL were detected in plasma and correlated with brain injury. The C-score correlated with early neurologic injury and predicted neurologic outcome. In a rat CA model, a significant reduction in hippocampal CL content corresponded to CL released from the brain into systemic circulation. In conclusion brain-specific CL species accumulate in plasma after CA and can be used to predict injury severity and outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.